Interventional cardiologists and cardiothoracic surgeons throughout the United States, North and South America, Europe, Asia and Australia, who treat patients with congenital heart disease, will gather at Nationwide Children’s Hospital June 16-18, 2008 for the third International Symposium on the Hybrid Approach to Congenital Heart Disease (ISHAC).
The 2006 ISHAC was the first of its kind dedicated to exploring advancements in “Hybrid” management strategies which combine surgical and transcatheter therapies in order to minimize the cumulative impact of treatment for complex congenital heart disease (CHD). In the U.S. alone, more than 40,000 babies are born with some form of CHD and many require high risk surgical procedures. A June 2008 report by the prestigious Advisory Board noted, “This procedure is becoming increasingly viewed as a must-have for leading children’s hospitals. The number of Hybrid pediatric labs is eventually expected to increase to the point where nearly all progressive children’s hospitals focused on advanced cardiac work have them.”
During Hybrid procedures, cardiothoracic surgeons and interventional cardiologists work collaboratively to correct defects in the heart, often with the use of stents and devices delivered through limited surgical access. Nationwide Children’s is considered the benchmark institution in this area where two uniquely designed Hybrid Cardiac Catheterization Suites were opened in June, 2004 – the first in the world dedicated to this new therapy. In November 2007, Nationwide Children’s opened the first dedicated state-of-the-art Hybrid Congenital Cardiac Operating Suite in the U.S. This operating suite is designed specifically around the cardiac surgeon and cardiac surgical patient, offering new advanced access and imaging in an operating room environment. The Suite facilitates rapid information sharing and features new technology from TOSHIBA Medical Systems and Maquet Surgical Workplaces.
The Symposium features lectures and panel discussions from international pioneers in the field, as well as live case demonstrations broadcast from the Hybrid Suites at The Heart Center at Nationwide Children’s Hospital. A unique Skills Workshop will be offered to a limited number of participants providing hands-on experience performing Hybrid procedures. Live cases will be broadcasted from Nationwide Children’s and The Ohio State University as well as Rush University Medical Center in Chicago.
Keynote speakers will be Edward L. Bove, MD, and Terry D. King, MD. Dr. Bove is the Head of the Section of Cardiac Surgery and Chief of Pediatric Cardiac Surgery at the University of Michigan Health System. He serves on the American Board of Thoracic Surgery and is listed in Who’s Who in Health and Medical Services and the Best Doctors in America. Dr. Bove is considered one of the world’s outstanding pediatric cardiac surgeons and is particularly renowned for his work with hypoplastic left heart syndrome. Dr. King is the Medical Director of Pediatric Services at St. Francis Medical Center in Monroe, Louisiana and Clinical Professor of Pediatrics at Tulane University School of Medicine. In 1975, Dr. King became the first person to implant a device non-surgically to close an atrial septal defect, a hole between the upper chambers of the heart, in a human being.
Symposium directors are John P. Cheatham, MD, George H. Dunlap Endowed Chair in Interventional Cardiology, Director of Cardiac Catheterization and Interventional Therapy and Co-Director of The Heart Center at Nationwide Children’s, and Mark Galantowicz, MD, Murray D. Lincoln Endowed Chair in Cardiothoracic Surgery, Co-Director of The Heart Center and Chief of Cardiothoracic Surgery at Nationwide Children’s. Both are faculty members of The Ohio State University College of Medicine. Drs. Cheatham and Galantowicz have organized this world-class event to encourage international discussion for potential Hybrid cardiac procedures that will result in improved outcomes while decreasing risks. The target audience consists of not only surgeons and interventional cardiologists, but also other members of heart centers who help care for children and adults with CHD.
ISHAC Symposium has received financial support from the AGA Medical Corporation, Toshiba Medical Systems, Argon, Arrow, Beijing Zenomed Scientific Co. Ltd., Boston Scientific, B Braun, Cook, Cordis, Edwards Life Science, ev3, HeartLab (Agfa), Maquet, Medtronic, Mobile Aspects, Inc., NuMED, pfm AG, Philips, Scientific Software Solutions, Stryker and W.L. Gore. More information on ISHAC is available on the Web at www.hybridsymposium.com.
The Heart Center at Nationwide Children’s Hospital is a regional, national and international referral center for the diagnosis and treatment of all forms of CHD and acquired cardiomyopathy in both pediatric and adult patients. After opening the unique Hybrid Suites in 2004, a prototype five axis positioner and biplane flat panel detectors from Toshiba Medical Systems were installed in July 2005. Unparalleled patient access, cardiac imaging and telemedicine capabilities are now possible. Visitors from around the world visit the Hybrid Suites in order to construct similar facilities at their own institutions. In November 2007, Nationwide Children’s opened the first dedicated Hybrid Congenital Cardiac Operating Suite in the U.S. The Operating Suite features more than 900 square feet of working space and is designed specifically around the cardiac surgeon and cardiac surgical patient, offering new advanced access and imaging in an operating room environment.